Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Other Gross PP&E Adjustments (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $13.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 14.82% to $13.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.5 million through Dec 2025, up 14.82% year-over-year, with the annual reading at $13.5 million for FY2025, 14.82% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $13.5 million at Fulcrum Therapeutics, up from $13.4 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $14.6 million in Q4 2021, with the low at $5.3 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $11.0 million, with a median of $11.2 million recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments crashed 62.88% in 2022, then skyrocketed 61.5% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $14.6 million in 2021, then crashed by 45.56% to $8.0 million in 2022, then rose by 29.81% to $10.3 million in 2023, then rose by 13.97% to $11.8 million in 2024, then rose by 14.82% to $13.5 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $13.5 million, $13.4 million, and $12.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.